CYP2C9 genotype detecting primer-probe set and kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHANGSHA 3G BIOTECH
- Publication Date
- 2017-01-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of in vitro nucleic acid detection, in particular to a primer probe set and a kit for detecting CYP2C9 genotyping. Background technique
[0002] Cytochrome P450 2C9 (Cyt℃chrome P450 2C9, CYP2C9) accounts for 20% of the total amount of P450 in liver microsomes, and can catalyze the metabolism of many commonly used clinical drugs, and its importance in clinical drug metabolism has been paid more and more attention. CYP2C9 has a high degree of genetic polymorphism, and the more common gene mutants are CYP2C9*2 (rs1799853) and CYP209*3 (rs1057910), whose encoded enzyme activities are respectively 30% and 80% lower than wild-type CYP2C9*1, resulting in Individuals with CYP2C9 mutations require lower doses of warfarin. Individuals carrying these two alleles need a longer time to reach the steady-state concentration after taking warfarin, and have a higher risk of bleeding in the initial stage of use. Therefore, w...